How did TKR's Q1 2024 earnings surprise impact short-term trading?

Terkila Pharmaceuticals (TKR)'s Q1 2024 earnings surprise had a positive impact on short-term trading, as evidenced by the backtest results. The 3-day win rate was 58.33%, the 10-day win rate was 83.33%, and the 30-day win rate was 50.00% following the earnings beat expectations event. The maximum return observed was 9.98% over 30 days, indicating that there was potential for gains in the short term after the earnings surprise was disclosed.